Covalon Technologies Ltd V.COV

Alternate Symbol(s): CVALF

Healthcare Biotechnology

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.

TSXV:COV - Post by User

Covalon Technologies Ltd

<< Previous

Bullboard Posts

Next >>

Post by mcapproon Sep 14, 2021 7:36am

355 Views

Post# 33853814

More insider buying

Insider Filings

Latest 10 SEDI filings for COV within the last 6 months

View on INK Research

Amended Filing

As of 11:59pm ET September 14th, 2021

Filing Date	Transaction Date	Insider Name	Ownership Type	Securities	Nature of transaction	Volume or Value	Price
Sep 13/21	Sep 10/21	Boloor, Amir	Direct Ownership	Common Shares	10 - Acquisition in the public market	25,600	$2.69
Sep 13/21	Sep 9/21	Boloor, Amir	Direct Ownership	Common Shares	10 - Acquisition in the public market	5,000	$2.46
Sep 12/21	Sep 8/21	Boloor, Amir	Direct Ownership	Common Shares	10 - Acquisition in the public market	45,000	$2.28
Sep 10/21	Sep 8/21	Cordiano, Joseph	Direct Ownership	Common Shares	51 - Exercise of options	5,000	$1.29
Sep 10/21	Sep 8/21	Cordiano, Joseph	Direct Ownership	Options	52 - Expiration of options	-5,000
Sep 9/21	Sep 8/21	Cordiano, Joseph	Direct Ownership	Options	51 - Exercise of options	-5,000	$1.29